ME Stock Price, Chart, Stats & News
23andMe Holding Co. (ME) does not currently pay a dividend.
ME chart
Fundamentals
Gross margin | 53.33% |
Operating margin | -114.00% |
Pretax margin | -112.33% |
Net margin | -134.54% |
Effective tax rate | 3.49% |
ROA | -163.04% |
ROE | -552.02% |
D/E | 0.83x |
Interest coverage ratio | – |
ME valuation
P/E | – |
P/S | 0.09x |
P/B | 0.51x |
P/CF | -0.11x |
P/FCF | -0.10x |
P/OCF | -0.11x |
PEG | -0.00x |
EV multiple | -0.20x |
About
23andMe Holding Co. is a prominent direct-to-consumer genetic testing firm, structured around two primary business units: Consumer & Research Services and Therapeutics. Through its Consumer & Research Services division, the company provides individuals with a comprehensive suite of genetic reports, derived from a simple saliva sample collected via their proprietary kit. These reports offer insights into customers' genetic ancestral origins, predispositions to certain personal health risks, the likelihood of being a carrier for rare conditions that could be passed to offspring, and how their genetic makeup might influence responses to various medications.
Similar securities
Based on sector and market capitalization
